113 related articles for article (PubMed ID: 12000045)
1. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris.
Umemoto S; Suzuki N; Fujii K; Fujii A; Fujii T; Iwami T; Ogawa H; Matsuzaki M
Am J Cardiol; 2000 Mar; 85(6):715-9. PubMed ID: 12000045
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
Hung MJ; Cherng WJ; Cheng CW; Li LF
Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
5. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina.
Shinozaki K; Suzuki M; Ikebuchi M; Takaki H; Hara Y; Tsushima M; Harano Y
Circulation; 1995 Oct; 92(7):1749-57. PubMed ID: 7671357
[TBL] [Abstract][Full Text] [Related]
7. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions.
Suzuki H; Kawai S; Aizawa T; Kato K; Sunayama S; Okada R; Yamaguchi H
J Am Coll Cardiol; 1999 Jan; 33(1):198-205. PubMed ID: 9935030
[TBL] [Abstract][Full Text] [Related]
8. Decrease in plasma adiponectin concentrations in patients with variant angina pectoris.
Hong SJ; Seo HS; Rha SW; Oh DJ; Kwon JA; Lee KN; Jang YS; Ro YM; Park CG
Circ J; 2006 Apr; 70(4):414-8. PubMed ID: 16565557
[TBL] [Abstract][Full Text] [Related]
9. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
[TBL] [Abstract][Full Text] [Related]
10. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
Ford ES; Giles WH
J Clin Epidemiol; 2000 Jan; 53(1):95-102. PubMed ID: 10693909
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
[TBL] [Abstract][Full Text] [Related]
12. Low serum apolipoprotein A-I level in patients with vasospastic angina.
Shirai K; Nii T; Imamura M; Kawano T; Mori T; Nakashima Y; Sasaki J; Arakawa K
Am Heart J; 1993 Feb; 125(2 Pt 1):320-3. PubMed ID: 8427122
[TBL] [Abstract][Full Text] [Related]
13. Impact of high-density lipoprotein cholesterol level in patients with variant angina pectoris.
Sugano Y; Anzai T; Yagi T; Noma S
Int J Cardiol; 2010 Apr; 140(2):175-81. PubMed ID: 19108908
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina.
Miwa K; Miyagi Y; Fujita M
J Am Coll Cardiol; 1995 Sep; 26(3):632-8. PubMed ID: 7642852
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of plasma concentration of macrophage colony-stimulating factor in patients with vasospastic angina].
Tomimura M; Saitoh T; Kishida H; Kusama Y; Takano T
J Cardiol; 2002 Jan; 39(1):19-27. PubMed ID: 11828794
[TBL] [Abstract][Full Text] [Related]
16. [Levels of endothelins in plasma of patients with variant angina].
Salomon P; Halawa B
Pol Arch Med Wewn; 1994 Jul; 92(1):47-53. PubMed ID: 7971477
[TBL] [Abstract][Full Text] [Related]
17. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
18. [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris].
Katayama N; Nakao K; Horiuchi K; Kasanuki H; Honda T
J Cardiol; 2005 Aug; 46(2):63-70. PubMed ID: 16127895
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma fibrinogen and coronary heart disease in women.
Eriksson M; Egberg N; Wamala S; Orth-Gomér K; Mittleman MA; Schenck-Gustafsson K
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):67-72. PubMed ID: 9888868
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and mortality of vasospastic angina pectoris hospitalised patients in Finland: a population-based registry cohort study.
Pikkarainen E; Blomster J; Sipilä J; Rautava P; Kytö V
BMJ Open; 2019 Nov; 9(11):e030768. PubMed ID: 31685505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
